Clinical Trial Update: Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FTY720 with mycophenolate mofetil in de novo adult renal transplant recipients has completed; the update discusses efficacy and safety o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• FTY720 (fingolimod)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED